{
  "id": "b1e7c27cdd6136b3",
  "title": "Arrowhead receives Health Canada authorisation for Redemplo to treat FCS",
  "description": "20260106T130000Z",
  "content": "",
  "source": "pharmaceutical-business-review.com",
  "source_url": "https://www.pharmaceutical-business-review.com/news/arrowhead-health-canada-authorisation/",
  "published_at": "20260106T130000Z",
  "fetched_at": "2026-01-07T00:22:40.638561+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.pharmaceutical-business-review.com/news/arrowhead-health-canada-authorisation/",
    "url_mobile": "https://www.pharmaceutical-business-review.com/news/arrowhead-health-canada-authorisation/amp/",
    "title": "Arrowhead receives Health Canada authorisation for Redemplo to treat FCS",
    "seendate": "20260106T130000Z",
    "socialimage": "https://www.pharmaceutical-business-review.com/wp-content/uploads/2026/01/PT-06-01-2025-shutterstock_742803865.jpg",
    "domain": "pharmaceutical-business-review.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}